Results of POUT - A phase III randomised trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)

Alison Birtle (Plenary Speaker)
Mark Johnson (Contributor)
Roger Kockelbergh (Contributor)
Frank Keeley (Contributor)
Jim Catto (Contributor)
Bryan, R. (Contributor)
John Chester (Contributor)
Robert Jones (Contributor)
Micki Hill (Contributor)
Jenny Donovan (Contributor)
Ann French (Contributor)
Chris Harris (Contributor)
Thomas Powles (Contributor)
Rachel Todd (Contributor)
Lucy Tregellas (Contributor)
Caroline Wilson (Contributor)
Andrew WInterbottom (Contributor)
Rebecca Lewis (Contributor)
Emma Hall (Contributor)

Cancer and Genomic Sciences

Activity: Academic and Industrial events › Conference, workshop or symposium

Period	9 Feb 2018
Event title	ASCO Genitourinary Cancers Symposium 2018
Event type	Conference
Location	San Francisco, United StatesShow on map
Degree of Recognition	International

Related content

Research output
Improved Disease Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial
Research output: Contribution to journal › Article › peer-review
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
Research output: Contribution to journal › Article › peer-review
Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)
Research output: Contribution to journal › Abstract › peer-review
Peri-operative chemotherapy or surveillance in upper tract urothelial cancer (POUT - CRUK/11/027) - a randomised controlled trial to define standard post-operative management
Research output: Chapter in Book/Report/Conference proceeding › Conference contribution